Results 121 to 130 of about 1,017,492 (137)

Targeting inflammation in the treatment of type 2 diabetes: time to start

Nature Reviews Drug Discovery, 2014
Marc Y Donath
exaly  

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

New England Journal of Medicine, 1993
P Cleary, D M Nathan, C Siebert
exaly  

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

New England Journal of Medicine, 2008
Pavel Hamet, Paul Glasziou, Mark Emmanuel Cooper   +2 more
exaly  

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

New England Journal of Medicine, 2015
Christoph Wanner, John M. Lachin, Bernard Zinman   +2 more
exaly  

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

New England Journal of Medicine, 2001
Matti Uusitupa, Jaana Lindström, Johan G. Eriksson   +2 more
exaly  

Changes in Diabetes-Related Complications in the United States, 1990–2010

New England Journal of Medicine, 2014
Mohammed K. Ali, Nilka Ríos Burrows, Edward W. Gregg   +2 more
exaly  

Effects of Intensive Glucose Lowering in Type 2 Diabetes

New England Journal of Medicine, 2008
Hertzel C. Gerstein, Michael E Miller, John Buse   +2 more
exaly  

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

New England Journal of Medicine, 2016
Jochen Seufert, Mark Warren, Ildiko Lingvay   +2 more
exaly  

Targeting hepatic glucose metabolism in the treatment of type 2 diabetes

Nature Reviews Drug Discovery, 2016
Pere B. Puigserver, Kfir Sharabi, Clint D J Tavares   +2 more
exaly  

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

New England Journal of Medicine, 2019
Carol Pollock, Rajiv Agarwal, Bernard Zinman   +2 more
exaly